Free tool
Heavily traded stocks
We cover 8 companies whose typical session turns over more than $10.00M. The median market value in the group is $1.31B. Across the group, the median move over the past trading day is +1.13%. Price change over the past year runs from −14.2% to +554.4% across the middle 80 percent of the group, with a median of −0.9%.
Other lists in this group
Table
8 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +48.91% | Sep 21, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% | Sep 10, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% | Sep 9, 2026 |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% | Sep 24, 2026 |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% | Sep 23, 2026 |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% | Aug 31, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.